Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain copyright of the published papers and grant to the publisher the non-exclusive right to publish the article, to be cited as its original publisher in case of reuse, and to distribute it in all forms and media. Users are required to provide full bibliographic description of the original publication (authors, article title, journal title, volume, issue, pages), as well as its DOI code. In electronic publishing, users are also required to link the content with the original article published in the Ethiopian Medical Journal. Authors can enter separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of their work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
Main Article Content
Increased anti-M. Leprae PGL-I igm levels in a child who developed leprosy
Abstract
As part of a study that aimed at reaching those at risk of developing leprosy through screening of household contacts, a child aged 7 was included as contact of a multibacillary leprosy patient. This study was conducted in Kokosa, hot spot area in Oromia Region, Ethiopia. Compared to other contacts, this child showed increased levels of
anti-M. leprae Phenolic glycolipid-I (PGL-I) IgM antibodies as assessed by up-converting lateral flow assay (UCP
-LFA) at initial and second-time screening and developed leprosy three years later. Therefore, the anti-PGL-I IgM
UCP-LFA can serve as an additional diagnostic field tool in leprosy control programs.
